by Marisa Meyers | Oct 16, 2024 | Report
Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...
by Marisa Meyers | Feb 6, 2024 | Report
Physician Engagement in a Time of Accelerated Professional Burnout As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...
by Marisa Meyers | Jan 30, 2024 | Report
Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023 In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...
by Marisa Meyers | Jan 24, 2024 | Report
HCP Perspectives 1 ½ Years After Dobbs v. Jackson Women’s Health Organization Our new Instant Insights report delves into the aftermath of the Dobb’s decision, examining its impact on patients and healthcare professionals. Our objectives were threefold: Explore...
by Marisa Meyers | Nov 7, 2023 | Report
What Doctors thought of this year’s ESMO Event Reaching European attendees, our 2023 Post-ESMO report sought to understand the event’s areas of greatest interest. 95 European oncologists and haematologist-oncologists shared with us the findings and developments...
by Marisa Meyers | Nov 1, 2023 | Report
Prescriber Perceptions around CRISPR in 2023 Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.In considering the 2019 research, InCrowd wanted to...
